Drug recall D-0265-2022
Product
5% Dextrose Injection, USP, 50 mL ADD-Vantage Unit, Rx only, Distributed by Hospira, INC., Lake Forest, IL 60045 USA, NDC 0409-7100-68/0409-7100-66
Reason for recall
Lack of sterility assurance: bag has the potential to leak.
Lots and codes
Lot: 4923608 Exp. 1MAY2022
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 765 bags
- Distribution
- USA Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 30, 2021
- Terminated
- July 12, 2023
Related products
- Dextrose – drug information
- NDC 0409-7100 Dextrose · Dextrose Monohydrate 50 mg/mL · Hospira, Inc.